PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTION BETWEEN DWP16001, A NOVEL SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR, AND METFORMIN IN HEALTHY SUBJECTS.

被引：0
作者：
Chung, W. [1 ]
Lee, S. [1 ]
Na, J. [1 ]
Lee, S. [1 ]
Lee, S. [1 ]
Cho, J. [1 ]
Jang, I. [1 ]
机构：
[1] Seoul Natl Univ, Seoul, South Korea
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2021年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-039
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetic and pharmacodynamic interactions between metformin and a novel dipeptidyl peptidase-4 inhibitor, evogliptin, in healthy subjects
    Rhee, Su-jin
    Choi, YoonJung
    Lee, SeungHwan
    Oh, Jaeseong
    Kim, Sung-Jin
    Yoon, Seo Hyun
    Cho, Joo-Youn
    Yu, Kyung-Sang
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 2525 - 2534
  • [22] Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Henagliflozin, a Novel Selective Inhibitor of Sodium-Glucose Cotransporter 2, in Healthy Subjects Following Single- and Multiple-dose Administration
    Zhang, Yi-fan
    Liu, Yan-mei
    Yu, Chen
    Wang, Ya-ting
    Zhan, Yan
    Liu, Hai-yan
    Zou, Jian-jun
    Jia, Jing-ying
    Chen, Qian
    Zhong, Da-fang
    CLINICAL THERAPEUTICS, 2021, 43 (02) : 396 - 409
  • [23] No pharmacokinetic interaction between saxagliptin and digoxin in healthy subjects.
    Boulton, D. W.
    Li, L.
    Patel, C. G.
    Komoroski, B. J.
    Whigan, D.
    Frevert, E. U.
    Kornhauser, D. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S93 - S93
  • [24] No pharmacokinetic interaction between nebivolol and furosemide in healthy subjects.
    Morton, TL
    Liu, S
    Phillips, JL
    Donnelly, CM
    Rackley, RJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P79 - P79
  • [25] Pharmacokinetic interaction study between metformin and a novel dipeptidyl peptidase-IV (DPP-IV) inhibitor PSN9301 in healthy subjects.
    Boinpally, R. R.
    Wolf, J.
    Savell, A.
    Clark, G.
    Hamilton, M.
    Rachman, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 : S106 - S106
  • [26] No pharmacokinetic interaction between trimethoprim and paliperidone ER in healthy subjects.
    Cleton, A
    Cleton, A
    Talluri, K
    Leempoels, J
    Thyssen, A
    Janssens, L
    Eerdekens, M
    Boom, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P22 - P22
  • [27] Pharmacokinetic interaction between tadalafil and bosentan in healthy male subjects.
    Wrishko, Rebecca E.
    Dingemanse, Jasper
    Yu, Albert
    Darstein, Christelle
    Phillips, Diane L.
    Mitchell, Malcolm I.
    CHEST, 2006, 130 (04) : 254S - 254S
  • [28] Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Sunkara, G
    Reynolds, CV
    Pommier, F
    Humbert, H
    Yeh, CM
    McLeod, J
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09) : 1067 - 1067
  • [29] Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in healthy subjects
    Stocker, Sophie L.
    Williams, Kenneth M.
    McLachlan, Andrew J.
    Graham, Garry G.
    Day, Richard O.
    CLINICAL PHARMACOKINETICS, 2008, 47 (02) : 111 - 118
  • [30] Pharmacokinetic and Pharmacodynamic Interaction between Allopurinol and Probenecid in Healthy Subjects
    Sophie L. Stocker
    Kenneth M. Williams
    Andrew J. McLachlan
    Garry G. Graham
    Richard O. Day
    Clinical Pharmacokinetics, 2008, 47 : 111 - 118
12345